TargetRx Inc.
This article was originally published in Start Up
Executive Summary
The founders of TargetRx think pharmaceutical firms ought to start early and continue doing marketing research throughout a product's life cycle. The start-up plans to seek the opinions of a wide range of specialists--negative as well as positive opinions, from prescribers and non-prescribers alike--which management says will yield vital strategic insights..
You may also be interested in...
E-Medical Market Research
Internet-based market research has become the norm in many areas of commerce, but the pharmaceutical industry is only just beginning to adopt the practice. The trend is being pushed forward by young companies that claim they can help drugmakers get from doctors the sorts of information they value--only more efficiently and cost-effectively than ever before. The web will also enable the collection of new types of information and insights, these start-ups claim.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.